Signal Over Noise: A Framework for AI-Driven Drug Repurposing and Target Identification in Pharma R&D

Discover how AI, knowledge graphs, and multi-signal reasoning are transforming pharmaceutical R&D by uncovering hidden relationships across scientific literature, omics data, clinical evidence, and proprietary research. This white paper explores how connected data infrastructure enables faster, explainable drug repurposing and target identification while reducing development costs and timelines. Through the real-world case of baricitinib, it demonstrates how modern AI moves beyond simple search to generate scientifically grounded, evidence-backed hypotheses that accelerate innovation.

What You’ll Learn Inside:

• Why traditional pharmaceutical R&D struggles with disconnected data silos
• How knowledge graphs enable AI-driven drug repurposing and target discovery
• The baricitinib case study and what it teaches about AI-assisted hypothesis generation
• The four essential data layers behind multi-signal AI reasoning
• Building an explainable, scientifically validated AI framework for drug discovery
• A practical four-phase roadmap for implementing knowledge graph–driven R&D
• The strategic value of integrating proprietary research with public biomedical data
• How quantum-enhanced molecular simulation is shaping the future of precision drug discovery

Whether you’re leading pharmaceutical research, computational biology, or AI innovation, this white paper provides a practical framework for building explainable, data-driven drug discovery workflows that improve scientific decision-making and accelerate clinical translation.